Ignite Creation Date:
2025-12-24 @ 5:13 PM
Ignite Modification Date:
2025-12-26 @ 12:30 PM
Study NCT ID:
NCT02635750
Status:
COMPLETED
Last Update Posted:
2024-08-20
First Post:
2015-12-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Investigation of Pharmacokinetic Drug-drug Interaction of BI 409306 and Donepezil in Healthy Male and Female Subjects
Sponsor:
Boehringer Ingelheim
Organization:
Study Overview
Official Title:
A Study to Investigate the Pharmacokinetic Drug-drug Interaction Following Oral Administration of BI 409306 and Donepezil in Healthy Male and Female Subjects
Status:
COMPLETED
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Part I:
To investigate whether and to what extent donepezil affects single dose pharmacokinetics of BI 409306
Part II:
To investigate whether and to what extent BI 409306 affects the single dose pharmacokinetics of donepezil
To investigate whether and to what extent donepezil affects single dose pharmacokinetics of BI 409306
Part II:
To investigate whether and to what extent BI 409306 affects the single dose pharmacokinetics of donepezil
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 2015-001694-40 | EUDRACT_NUMBER | None | View |